Dietary Exposure
0
Pipeline Programs
5
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programIdentify Biomarkers of Dietary Intake in Healthy SubjectsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alliance Pharmaceuticalsvegetable combination 1
Martin PharmaceuticalsUVB-exposed button mushrooms
Human BioSciencesIdentify Biomarkers of Dietary Intake in Healthy Subjects
Clinical Trials (3)
Total enrollment: 610 patients across 3 trials
Tasting Plant Forward Meals
Start: Jan 2026Est. completion: Dec 202680 patients
N/ARecruiting
Bioavailability of Vitamin D Photoisomers From UVB-exposed Button Mushrooms
Start: Jan 2023Est. completion: Jul 202436 patients
N/AUnknown
Discovery of Novel Biomarkers of Dietary Exposure in the EPIC Calibration Study
Start: Apr 2012Est. completion: Feb 2013494 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 610 patients
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.